Axsome Thera (AXSM)
101.72 x 1 115.00 x 5
Post-market by (Cboe BZX)
103.83 +0.30 (+0.29%) 04/15/25 [NASDAQ]
101.72 x 1 115.00 x 5
Post-market 104.00 +0.17 (+0.16%) 16:38 ET
for Tue, Apr 15th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -287,216 | -239,238 | -187,134 | -130,403 | -102,901 |
Depreciation Amortization | 10,598 | 9,408 | 5,885 | 1,153 | 865 |
Accounts receivable | -47,181 | -57,121 | -37,699 | N/A | 0 |
Accounts payable and accrued liabilities | 31,318 | 2,074 | 25,456 | -355 | 2,561 |
Other Working Capital | 33,478 | -28,238 | 22,552 | -858 | 421 |
Other Operating Activity | 130,593 | 168,035 | 54,429 | 22,237 | 20,598 |
Operating Cash Flow | $-128,410 | $-145,080 | $-116,511 | $-108,226 | $-78,457 |
Cash Flows From Investing Activities | |||||
PPE Investments | -270 | -582 | -702 | -308 | -46 |
Net Acquisitions | N/A | N/A | -53,000 | N/A | N/A |
Investing Cash Flow | $-270 | $-582 | $-53,702 | $-308 | $-46 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 85,000 | 45,000 | N/A | 50,000 |
Debt Repayment | -990 | N/A | N/A | N/A | -21,660 |
Common Stock Issued | 71,464 | 271,169 | 250,014 | 11,838 | 15,175 |
Other Financing Activity | -12,634 | -25,156 | -10,432 | -708 | -1,103 |
Financing Cash Flow | $57,840 | $331,013 | $284,582 | $11,130 | $42,413 |
Beginning Cash Position | 386,193 | 200,842 | 86,473 | 183,877 | 219,966 |
End Cash Position | 315,353 | 386,193 | 200,842 | 86,473 | 183,876 |
Net Cash Flow | $-70,840 | $185,351 | $114,369 | $-97,404 | $-36,090 |
Free Cash Flow | |||||
Operating Cash Flow | -128,410 | -145,080 | -116,511 | -108,226 | -78,457 |
Capital Expenditure | -270 | -582 | -702 | -308 | -46 |
Free Cash Flow | -128,680 | -145,662 | -117,213 | -108,534 | -78,503 |